Rofecoxib - Wikipedia, the free encyclopedia
Rofecoxib (pronounced /Rofecoxib/) is a nonsteroidal anti-inflammatory drug marketed by Merck & Co. to treat osteoarthritis, acute pain conditions, and dysmenorrhoea. Rofecoxib was approved as safe and effective by the Food and Drug Administration (FDA) on May 20, 1999 and was subsequently marketed under the brand name Vioxx, Ceoxx and Ceeoxx.Mode of action · Adverse drug reactions · Withdrawal · Litigation · Other effects